Cargando…
Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
In this study, we investigated the proliferating cell index by the percentage of Ki-67 expressing cells (Ki-67 LI) and the apoptotic index (AI) by the number of morphologically apoptotic cells per 1000 carcinoma cells in haematoxylin and eosin sections of 76 hepatocellular carcinomas (HCC). Both ind...
Autores principales: | Ito, Y, Matsuura, N, Sakon, M, Takeda, T, Umeshita, K, Nagano, H, Nakamori, S, Dono, K, Tsujimoto, M, Nakahara, M, Nakao, K, Monden, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362905/ https://www.ncbi.nlm.nih.gov/pubmed/10574266 http://dx.doi.org/10.1038/sj.bjc.6690758 |
Ejemplares similares
-
The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2000) -
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2001) -
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression
por: Ota, H, et al.
Publicado: (2005) -
Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
por: Noda, T, et al.
Publicado: (2009) -
PTEN/MMAC1 Mutation and Frequent Loss of Heterozygosity Identified in Chromosome 10q in a Subset of Hepatocellular Carcinomas
por: Fujiwara, Yoshiyuki, et al.
Publicado: (2000)